Boston Scientific Asserts Stent Patents In Netherlands

Law360, New York (December 13, 2005, 12:00 AM EST) -- Medical device maker Boston Scientific has filed a patent infringement suit against Singapore-based Biosensors Group in a Dutch court, adding another lawsuit to the extensive litigation over highly profitable stent patents.

Boston Scientific and Canadian drug company Angiotech Pharmaceuticals have filed a suit against Biosensors, alleging the company’s drug eluding stent Axxion infringes patents controlled jointly by the two companies.

Biosensors said in a statement that despite the claims of the companies, its Dutch unit Occam International had received permission to sell its stents in Europe....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.